𝐅𝐃𝐀 𝐖𝐚𝐫𝐧𝐢𝐧𝐠 𝐋𝐞𝐭𝐭𝐞𝐫: 𝐖𝐡𝐞𝐧 𝐂𝐨𝐦𝐩𝐥𝐢𝐚𝐧𝐜𝐞 𝐅𝐚𝐢𝐥𝐬

𝐅𝐃𝐀 𝐖𝐚𝐫𝐧𝐢𝐧𝐠 𝐋𝐞𝐭𝐭𝐞𝐫: 𝐖𝐡𝐞𝐧 𝐂𝐨𝐦𝐩𝐥𝐢𝐚𝐧𝐜𝐞 𝐅𝐚𝐢𝐥𝐬

A recent warning letter issued by the U.S. Food and Drug Administration FDA to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (#DSCSA), including failing to source products from authorized trading partners and purchasing only serialized drug products.

If you can’t prove where your product came from, you’re already out of compliance.

Every shipment across the pharmaceutical supply chain must be accompanied by serialized data exchange, typically in the form of an EPCIS file.

The pharmacy in question failed to demonstrate that the products in its possession were:

=Linked to a legitimate trading partner

=Supported by valid transaction data (EPCIS / transaction history / invoice)

And that’s exactly where enforcement kicks in.

The FDA is actively inspecting, validating, and enforcing DSCSA requirements across the market.

This level of control reflects a serious push toward securing the pharmaceutical supply chain end-to-end.